Expand XENE Menu
XENE MENU

Xenon Pharmaceuticals - Common Shares (XENE) closed at $37.75 on November 18, 2026, down 2.7% from the previous close, on volume of 1,192,446 shares (30-day average 1,312,285).

Key numbers
  • Last close: $37.75 (November 18, 2026)
  • 52-week range: $33.38 to $72.66
  • Market value: $3.7 billion
  • 30-day implied volatility (IV30): 28.7%
  • Option volume: 1,363 contracts (1,115 calls, 248 puts); 30-day average 447

Data as of November 18, 2026.

XENE Stock Summary and Trading Ideas (Xenon Pharmaceuticals - Common Shares | NASDAQ:XENE)

Charts for Today's Stock Price and Implied Volatility in Xenon Pharmaceuticals - Common Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for XENE by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 11, 2026 Call Spread 21-Jan-2840 : 60 C 230

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 18, 2026. See the largest for 5, 30, 60 and 90 days

Trading Statistics

Key Ratios

Xenon Pharmaceuticals - Common Shares (XENE) Frequently Asked Questions

What does Xenon Pharmaceuticals - Common Shares do?

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

What symbol and exchange does Xenon Pharmaceuticals - Common Shares shares trade?

Xenon Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol XENE.

What is Xenon Pharmaceuticals - Common Shares stock price doing today?

As of November 19, 2026, XENE stock price declined to $37.56 with 1,205,458 million shares trading.

What is Xenon Pharmaceuticals - Common Shares's Beta?

XENE has a beta of 0.23, meaning it tends to be less sensitive to market movements. XENE has a correlation of 0.00 to the broad based SPY ETF.

How much is Xenon Pharmaceuticals - Common Shares worth?

XENE has a market cap of $3.69 billion. This is considered a Mid Cap stock.

What is the highest and lowest price Xenon Pharmaceuticals - Common Shares traded in the last 3 year period?

In the last 3 years, XENE traded as high as $72.66 and as low as $26.74.

What are the top ETFs holding Xenon Pharmaceuticals - Common Shares?

The top ETF exchange traded funds that XENE belongs to (by Net Assets): IWM, TCAF, IWO, IBB, VTWO.

Is Xenon Pharmaceuticals - Common Shares (XENE) a good investment?

XENE has underperformed the market in the last year with a return of -7.5%, while the SPY ETF gained +9.6%. In the last 3 month period, XENE fell short of the market, returning -40.6%, while SPY returned -6.5%. However, in the most recent 2 weeks XENE has outperformed the stock market by returning -4.2%, while SPY returned -6.6%.

What are the support and resistance levels for Xenon Pharmaceuticals - Common Shares (XENE)?

XENE support price is $36.86 and resistance is $38.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XENE shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes